| Product Code: ETC12910446 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Mannose Phosphate Isomerase Deficiency Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Mannose Phosphate Isomerase Deficiency Market - Industry Life Cycle |
3.4 Ireland Mannose Phosphate Isomerase Deficiency Market - Porter's Five Forces |
3.5 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Mannose Phosphate Isomerase Deficiency Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of mannose phosphate isomerase deficiency in Ireland |
4.2.2 Advancements in genetic testing and diagnostic technologies |
4.2.3 Growing research and development activities focused on finding new treatments and therapies for the condition |
4.3 Market Restraints |
4.3.1 Limited availability and accessibility of specialized healthcare facilities for the treatment of mannose phosphate isomerase deficiency in Ireland |
4.3.2 High treatment costs associated with managing the condition |
4.3.3 Lack of approved specific therapies for mannose phosphate isomerase deficiency |
5 Ireland Mannose Phosphate Isomerase Deficiency Market Trends |
6 Ireland Mannose Phosphate Isomerase Deficiency Market, By Types |
6.1 Ireland Mannose Phosphate Isomerase Deficiency Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Genetic Disorder, 2021 - 2031F |
6.1.4 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Metabolic Disease, 2021 - 2031F |
6.1.5 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Rare Disease, 2021 - 2031F |
6.2 Ireland Mannose Phosphate Isomerase Deficiency Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Enzyme Replacement Therapy, 2021 - 2031F |
6.2.3 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Supportive Therapy, 2021 - 2031F |
6.2.4 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.3 Ireland Mannose Phosphate Isomerase Deficiency Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.4 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4 Ireland Mannose Phosphate Isomerase Deficiency Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Hospitals & Clinics, 2021 - 2031F |
6.4.3 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Research & Diagnostic Centers, 2021 - 2031F |
6.4.4 Ireland Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, By Pharmaceutical & Biotechnology, 2021 - 2031F |
7 Ireland Mannose Phosphate Isomerase Deficiency Market Import-Export Trade Statistics |
7.1 Ireland Mannose Phosphate Isomerase Deficiency Market Export to Major Countries |
7.2 Ireland Mannose Phosphate Isomerase Deficiency Market Imports from Major Countries |
8 Ireland Mannose Phosphate Isomerase Deficiency Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on mannose phosphate isomerase deficiency treatments |
8.2 Adoption rate of genetic testing for diagnosing mannose phosphate isomerase deficiency in Ireland |
8.3 Percentage of healthcare professionals trained in managing and treating the condition |
9 Ireland Mannose Phosphate Isomerase Deficiency Market - Opportunity Assessment |
9.1 Ireland Mannose Phosphate Isomerase Deficiency Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Mannose Phosphate Isomerase Deficiency Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Ireland Mannose Phosphate Isomerase Deficiency Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ireland Mannose Phosphate Isomerase Deficiency Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Mannose Phosphate Isomerase Deficiency Market - Competitive Landscape |
10.1 Ireland Mannose Phosphate Isomerase Deficiency Market Revenue Share, By Companies, 2024 |
10.2 Ireland Mannose Phosphate Isomerase Deficiency Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here